Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6T | 3.4T | 2.2T | 2.2T |
Cost of revenue | 1.7T | 1.7T | 1.4T | 1.4T |
Gross profit | 911.7B | 1.7T | 751.3B | 725.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 81.1B | 110.1B | 104.0B | 87.9B |
Other operating expenses | 3.2B | -3.7B | 668M | 8.4B |
Operating income | 728.2B | 1.3T | 651.0B | 577.3B |
Non operating interest income | ||||
Income | 20.4B | 19.1B | 13.8B | 10.1B |
Expense | 14.5B | 21.2B | 19.3B | 17.9B |
Other income expense | — | — | — | — |
Pretax income | 990.2B | 1.9T | 823.4B | 747.5B |
Tax provision | 155.4B | 338.5B | 147.1B | 130.4B |
Net income | 834.9B | 1.6T | 676.3B | 617.1B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 1.0T | 1.7T | 848.9B | 795.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -29.6B | -60.6B | -25.4B | -21.6B |
Preferred stock dividends | 0 | 0 | 0 | 0 |